Real-World Effectiveness, Corticosteroid-Sparing Effects, and Exploratory Immunological Correlates of Omalizumab Add-On Therapy in Hospitalized Patients with Acute Urticaria
Abstract
Background/Objectives: Hospitalized patients with acute urticaria often present with rapid symptom progression, severe pruritus, angioedema, and a high risk of short-term relapse. Systemic glucocorticoids provide rapid anti-inflammatory control but raise concerns about cumulative exposure and adverse effects. This real-world study evaluates whether adding omalizumab to systemic glucocorticoids improves efficacy, safety, and steroid-sparing outcomes and explores associated immunological correlates. Methods: This retrospective cohort study evaluated the real-world, off-label use of omalizumab as add-on therapy in hospitalized patients with acute urticaria treated between 2023 and 2026. We compared UAS7 scores, itch VAS, resolution times, the primary efficacy outcome of complete remission within 7 days, the key secondary efficacy outcome of recurrence within 14 days, corticosteroid exposure, adverse events, and immune-inflammatory markers. Propensity score matching (PSM) was used to reduce imbalances in measured baseline covariates, and a multivariable exploratory model with LASSO regression identified factors linked to short-term outcomes. Results: A total of 73 patients met the eligibility criteria and were included in the study, including 39 patients who received conventional glucocorticoid-centered therapy and 34 patients who received additional omalizumab. Measured baseline characteristics were generally comparable, although imbalances remained in sex and selected…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 73 participants or records.
Read the paper
Related studies
- Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects
- Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study
- Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
- Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.